5 Results for "

LRA

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "LRA" in MCE Product Catalog:

Cat. No.: HY-Y0493
CAS No.: 28230-32-2
Synonyms: HOOBt
Target:  

STAT HIV

Research Areas:  

Infection Cancer

HODHBt (HOOBt) inhibits STAT5-SUMO interaction by blocking SUMOylation of phosphorylated STAT5. HODHBt enhances the magnitude of IL-15 signaling and significantly increases the natural killer (NK) cell cytotoxicity phenotype and function and the generation of cytokine-induced memory-like (CIML) natural killer (NK) cells. HODHBt can be used for research of HIV-infection and cancer .
loading...
    loading...
Cat. No.: HY-100522
CAS No.: 1955550-51-2
Purity:  ≥98.0%
Target:  

Atg4 Autophagy

Research Areas:  

Cancer

FMK 9a is an autophagin-1 inhibitor with IC50 values of 80 and 73 μM in FRET and LRA assay.
loading...
    loading...
Cat. No.: HY-119490
CAS No.: 2109805-83-4
Research Areas:  

Infection

UMB-136 is a bromodomain inhibitor. UMB-136 is a promising latency-reversing agent (LRA) for HIV-1 eradication. UMB-136 reactivates HIV-1 in multiple cell models. UMB-136 enhances HIV-1 transcription and increases viral production through the release of P-TEFb .
loading...
    loading...
Cat. No.: HY-155599
CAS No.: 2982527-11-5
Target:  

HIV PKC

Research Areas:  

Infection

HIV-1 protease-IN-10 (Compound 2) has HIV-1 latency reversing activity (IC50: 0.22 μM). HIV-1 protease-IN-10 binds to the PKCδ C1b domain (IC50: 0.69 μM). HIV-1 protease-IN-10 has stability against esterase-mediated hydrolysis .
loading...
    loading...
Cat. No.: HY-180525
Target:  

Influenza Virus

Research Areas:  

Infection

PB2-IN-2 is an orally active PB2 inhibitor with RNA-dependent RNA Polymerase (RNP) IC50 = 0.2 nM, LRA (Ligand Receptor Assay) EC50 = 0.8 nM, Cytopathic Effect (CPE) EC50 = 0.1 nM. PB2-IN-2 exhibits broad-spectrum, nanomolar antiviral potency against a panel of influenza A strains (including H1N1pdm09, Lyon/1337/2007/H1N1, Tex12-Like/H3N2, PR/8/34/H1N1, WSN/1933/H1N1, rPR8(H1N1)/H7N9 with EC50 = 1.5, 3.6, 3.7, 13.8, 2.9 and 9.8 nM and all the CC50 values > 2 μM. PB2-IN-2 possesses an excellent pharmacokinetic profile and metabolic stability. PB2-IN-2 can be used for anti-influenza research .
loading...
    loading...